Into Absurdity @SubtleInduction

Joined November 2023

Tweets

14K
Followers

620
Following

659
Likes

11K

Into Absurdity @SubtleInduction

a month ago

@X you guys aree fucking retards. look at my posts , you think a bot is going to rite that shit? it's cuz i mocked rfk jr's dick eating one too many times, isn't it?

0 0 3 79 0

View Details

Into Absurdity @SubtleInduction

a month ago

@BillOccham0 The top 4 to me are pedantic distinctions, you had to use the word contradiction to describe counterargument, but contradiction is #4

0 0 0 3 0

View Details

Into Absurdity @SubtleInduction

a month ago

I am a human

0 0 1 52 1

View Details

Into Absurdity @SubtleInduction

a month ago

@emmaluvcherries @ObsvRetardation

0 0 1 15 0

View Details

Into Absurdity @SubtleInduction

3 months ago

If you want to buy the tops, you got to be willing to sell the bottoms.

0 0 2 128 0

View Details

Into Absurdity @SubtleInduction

3 months ago

Added back $SIMO from my tuesday sell. 10% lower

0 0 1 138 0

View Details

Into Absurdity @SubtleInduction

3 months ago

Adding $TENX v small position as this shit is likely v risky

0 0 0 87 0

View Details

Into Absurdity @SubtleInduction

3 months ago

I posted previously explaining why this + longer t1/2 should -> >> cAMP signaling for bero at = mass vs sema. Though remains to be proven how translates to outcomes. The conformational dynamics of biased agonism and downstream signaling differences are really interesting

Jen Can NuSH @JCanNuSH

3 months ago

🛎️Fantastic summary of the results out of ADA 2026 from @rn_flex for things not named CagriSema or retatrutide: Zenagamtide, Berobenatide, UBT251, enicepatide & orforglipron This paragraph in particular (focused on Pfizer’s berobenatide) was helpful to me about why it seems to

1 2 9 1K 6

0 0 1 97 0

View Details

Into Absurdity @SubtleInduction

3 months ago

$CRWD +100% from my april buy (which I posted at the time). Just sold half so now I can be mad whether it goes up or down.

0 0 0 99 1

View Details

Into Absurdity @SubtleInduction

3 months ago

Imagine your job is just to assign a narrative for the thing that's been happening for the past 6 months

*Walter Bloomberg @DeItaone

3 months ago

GOLDMAN: INVESTORS TRIM BIG TECH EXPOSURE Goldman Sachs says investors are reducing exposure to the Magnificent Seven as they favor AI beneficiaries, such as semiconductor companies, over hyperscalers funding heavy AI spending. The bank believes markets are rewarding companies

47 60 443 173K 34

0 0 1 99 0

View Details

Into Absurdity @SubtleInduction

3 months ago

Sold NKTR MDGL ALMS AAOI. Adding to IMVT RVMD PTGX TNGX. New positions PWR GOOG

0 0 0 74 0

View Details

Into Absurdity @SubtleInduction

3 months ago

$MDGL what a turd. I'm out of it.

Into Absurdity @SubtleInduction

4 months ago

$MDGL finally broke out on the daily yesterday after breaking out on the weekly last week

0 0 0 123 0

0 0 0 725 0

View Details

Into Absurdity @SubtleInduction

3 months ago

Bro got gynecomastia. Maybe he has liver cirrhosis (due to contracting Hep C from all those hookers) and will die soon 😂

Covie @covie_93

4 months ago

don jr got some bigger boobs and all of a sudden his father starts talking about having threesomes with his sons.

166 535 4K 37K 36

0 0 0 84 0

View Details

Covie @covie_93

4 months ago

Looks like someone forgot to eat his raccoon penis that morning.

FactPost @factpostnews

4 months ago

RFK Jr does 1/3 of a pull-up and walks away

743 779 14K 14.9M 1K

199 1K 28K 1.0M 404

View Details

Into Absurdity @SubtleInduction

3 months ago

@Ben1148x2 @covie_93 😂

0 0 0 13 0

View Details

Into Absurdity @SubtleInduction

4 months ago

$MEDP remains largest position at ~12% no trades, $Lly 7.5% net added over the past month, $UTHR 7% small add, $cort 6% no trades, $vrtx 4% some selling.

0 0 0 367 0

View Details

Into Absurdity @SubtleInduction

4 months ago

I like $BBIO a lot, will plan to hold it a bit longer. Took a 2% position 73.xx avg. Sold some $LLY I opportunistically bought last week (7% gain on that tranche, now ~7.5% position). Literally never heard a biopharma CEO use the term "ROIC" on an earnings call before 😂